2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) All Versions of this Article: ASN.2005090984v1 17/3/900    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kasiske, B. L. Articles by Snyder, J. J. Search for Related Content PubMed PubMed Citation Articles by Kasiske, B. L. Articles by Snyder, J. J.

Acute Myocardial Infarction and Kidney Transplantation

Bertram L. Kasiske^*, J. Ross Maclean and Jon J. Snyder

^* Department of Medicine, Hennepin County Medical Center, University of Minnesota College of Medicine, and Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota; and Bristol-Myers Squibb Company, Princeton, New Jersey

Address correspondence to: Dr. Bertram L. Kasiske, Department of Medicine, Hennepin County Medical Center, 701 Park Avenue, Minneapolis, MN 55415. Phone: 612-347-5871; Fax: 612-347-2003; E-mail: kasis001{at}umn.edu

Received for publication September 21, 2005. Accepted for publication December 31, 2005.

Although the risk for acute myocardial infarction (AMI) is lower after transplantation than on the waiting list, this risk may vary by patient population and may be different early versus late after transplantation. Risk factors for AMI were examined among 53,297 Medicare beneficiaries who were placed on the deceased-donor waiting list in 1995 to 2002. Early (3 mo) and late (>3 mo) effects of receiving a deceased- or living-donor kidney transplant were examined using time-dependent covariates in Cox nonproportional hazards analysis. Overall, transplantation was associated with a 17% lower adjusted risk for AMI (0.83; 95% confidence interval [CI] 0.77 to 0.90) versus the waiting list. However, the relative risk (versus the waiting list) for AMI was greater for deceased- compared to living-donor transplants, with both being much greater early (deceased-donor 3.57 [95% CI 3.21 to 3.96] compared to living-donor 2.81 [95% CI 2.31 to 3.42]) than late (deceased-donor 0.45 [95% CI 0.41 to 0.50] compared to living-donor 0.39 [95% CI 0.33 to 0.47]) posttransplantation. Individuals who were 65 yr of age had a much higher risk (versus 18- to 34-yr-olds) for AMI early posttransplantation (8.01; 95% CI 5.12 to 12.53) compared with the waiting list (3.68; 95% CI 3.98 to 4.54) or late posttransplantation (4.37; 95% CI 3.07 to 6.20). Black patients had less reduction in AMI risk (versus white patients) late posttransplantation (0.78; 95% CI 0.64 to 0.95) compared with early posttransplantation (0.60; 95% CI 0.48 to 0.74) or on the waiting list (0.62; 95% CI 0.56 to 0.68). The AMI risk that was associated with chronic kidney disease from diabetes (versus glomerulonephritis) was relatively greater on the waiting list (1.64; 95% CI 1.45 to 1.85) compared with early (1.34; 95% CI 1.08 to 1.68) and late (1.39; 95% CI 1.12 to 1.72) posttransplantation. Thus the risk reduction for AMI with transplantation versus the waiting list varies by patient population and time after transplantation.

This article has been cited by other articles:

				K. L. Lentine, L. A. R. Rey, S. Kolli, G. Bacchi, M. A. Schnitzler, K. C. Abbott, H. Xiao, and D. C. Brennan Variations in the Risk for Cerebrovascular Events after Kidney Transplant Compared with Experience on the Waiting List and after Graft Failure Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1090 - 1101. [Abstract] [Full Text] [PDF]

				K. L. Lentine, M. A. Schnitzler, D. C. Brennan, J. J. Snyder, P. J. Hauptman, K. C. Abbott, D. Axelrod, P. R. Salvalaggio, and B. Kasiske Cardiac Evaluation before Kidney Transplantation: A Practice Patterns Analysis in Medicare-insured Dialysis Patients Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1115 - 1124. [Abstract] [Full Text] [PDF]

				S. Aull-Watschinger, H. Konstantin, D. Demetriou, M. Schillinger, A. Habicht, W. H. Horl, and B. Watschinger Pre-transplant predictors of cerebrovascular events after kidney transplantation Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1429 - 1435. [Abstract] [Full Text] [PDF]

				A. C. Shirali and M. J. Bia Management of Cardiovascular Disease in Renal Transplant Recipients Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 491 - 504. [Abstract] [Full Text] [PDF]

				J. S. Gill Cardiovascular Disease in Transplant Recipients: Current and Future Treatment Strategies Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(Supplement_2): S29 - S37. [Abstract] [Full Text] [PDF]

				F. Moreso and J. M. Grinyo Graft dysfunction and cardiovascular risk--an unholy alliance Nephrol. Dial. Transplant., March 1, 2007; 22(3): 699 - 702. [Full Text] [PDF]

				R. Marcen, J. M. Morales, M. Arias, G. Fernandez-Juarez, G. Fernandez-Fresnedo, A. Andres, E. Rodrigo, J. Pascual, B. Dominguez, and J. Ortuno Ischemic Heart Disease after Renal Transplantation in Patients on Cyclosporine in Spain J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S286 - S290. [Abstract] [Full Text] [PDF]

				J. J. Snyder, B. L. Kasiske, and R. Maclean Peripheral Arterial Disease and Renal Transplantation J. Am. Soc. Nephrol., July 1, 2006; 17(7): 2056 - 2068. [Abstract] [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673